- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.35 Å
- Oligo State
- hetero-5-5-5-mer
- Ligands
- 5 x GLU: GLUTAMIC ACID(Non-covalent)
- 5 x IVM: (2aE,4E,5'S,6S,6'R,7S,8E,11R,13R,15S,17aR,20R,20aR,20bS)-6'-[(2S)-butan-2-yl]-20,20b-dihydroxy-5',6,8,19-tetramethyl-17 -oxo-3',4',5',6,6',10,11,14,15,17,17a,20,20a,20b-tetradecahydro-2H,7H-spiro[11,15-methanofuro[4,3,2-pq][2,6]benzodioxacy clooctadecine-13,2'-pyran]-7-yl 2,6-dideoxy-4-O-(2,6-dideoxy-3-O-methyl-alpha-L-arabino-hexopyranosyl)-3-O-methyl-alpha-L-arabino-hexopyranoside(Non-covalent)
IVM.2: 16 residues within 4Å:- Chain A: T.257, S.260, N.264, I.273, D.277, I.280, G.281, M.284, T.285, F.288
- Chain B: L.217, L.218, Q.219, I.222, P.223, M.226
13 PLIP interactions:7 interactions with chain A, 6 interactions with chain B- Hydrophobic interactions: A:T.257, A:I.273, A:I.273, A:M.284, A:F.288, B:I.222, B:P.223, B:M.226
- Hydrogen bonds: A:S.260, A:N.264, B:L.218, B:Q.219, B:Q.219
IVM.3: 16 residues within 4Å:- Chain A: L.218, Q.219, I.222, P.223, M.226
- Chain E: T.257, S.260, N.264, I.273, D.277, I.280, G.281, M.284, T.285, F.288
- Ligands: OCT.20
12 PLIP interactions:5 interactions with chain A, 7 interactions with chain E- Hydrophobic interactions: A:I.222, A:M.226, E:T.257, E:I.273, E:I.273, E:M.284, E:F.288
- Hydrogen bonds: A:L.218, A:Q.219, A:Q.219, E:S.260, E:N.264
IVM.8: 17 residues within 4Å:- Chain B: T.257, S.260, N.264, I.273, D.277, I.280, G.281, A.282, M.284, T.285, F.288
- Chain C: L.217, L.218, Q.219, I.222, P.223, M.226
14 PLIP interactions:6 interactions with chain C, 8 interactions with chain B- Hydrophobic interactions: C:I.222, C:P.223, C:M.226, B:T.257, B:I.273, B:I.273, B:M.284, B:F.288, B:F.288
- Hydrogen bonds: C:L.218, C:Q.219, C:Q.219, B:S.260, B:N.264
IVM.16: 18 residues within 4Å:- Chain C: T.257, S.260, N.264, I.273, D.277, I.280, G.281, A.282, M.284, T.285, F.288
- Chain D: L.217, L.218, Q.219, I.222, P.223, M.226, I.229
15 PLIP interactions:7 interactions with chain D, 8 interactions with chain C- Hydrophobic interactions: D:I.222, D:P.223, D:M.226, D:I.229, C:T.257, C:I.273, C:I.273, C:M.284, C:F.288, C:F.288
- Hydrogen bonds: D:L.218, D:Q.219, D:Q.219, C:S.260, C:N.264
IVM.19: 19 residues within 4Å:- Chain D: T.257, S.260, N.264, I.273, D.277, I.280, G.281, M.284, T.285, F.288
- Chain E: L.217, L.218, Q.219, I.222, P.223, C.225, M.226, I.229
- Ligands: OCT.17
12 PLIP interactions:7 interactions with chain E, 5 interactions with chain D- Hydrophobic interactions: E:I.222, E:P.223, E:M.226, E:I.229, D:T.257, D:F.288, D:F.288
- Hydrogen bonds: E:L.218, E:Q.219, E:Q.219, D:S.260, D:N.264
- 3 x LMT: DODECYL-BETA-D-MALTOSIDE(Non-covalent)
LMT.4: 8 residues within 4Å:- Chain A: H.299, I.300, N.302, A.303, G.304, T.305, W.308
- Ligands: LMT.9
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:N.302, A:G.304, A:T.305
- Salt bridges: A:H.299
LMT.5: 2 residues within 4Å:- Chain A: K.210, W.335
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:W.335
- Hydrogen bonds: A:K.210, A:K.210
LMT.9: 5 residues within 4Å:- Chain B: W.236, L.317, R.320
- Ligands: LMT.4, UND.12
3 PLIP interactions:2 interactions with chain B, 1 interactions with chain A- Hydrogen bonds: B:R.320, B:R.320, A:H.299
- 1 x CL: CHLORIDE ION(Non-functional Binders)
- 3 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.10: 6 residues within 4Å:- Chain B: Q.143, N.185, T.186, S.187, T.206, Q.208
4 PLIP interactions:4 interactions with chain B- Hydrophobic interactions: B:T.206
- Hydrogen bonds: B:Q.143, B:N.185, B:Q.208
NAG.14: 6 residues within 4Å:- Chain C: Q.143, N.185, T.186, S.187, T.206, Q.208
5 PLIP interactions:5 interactions with chain C- Hydrophobic interactions: C:T.206, C:Q.208
- Hydrogen bonds: C:Q.143, C:N.185, C:Q.208
NAG.21: 4 residues within 4Å:- Chain E: Q.143, N.185, T.186, Q.208
No protein-ligand interaction detected (PLIP)- 3 x OCT: N-OCTANE(Non-covalent)
OCT.11: 6 residues within 4Å:- Chain B: A.282, T.285, F.286, C.289, F.323, L.326
6 PLIP interactions:6 interactions with chain B- Hydrophobic interactions: B:A.282, B:F.286, B:F.286, B:F.286, B:F.323, B:L.326
OCT.17: 4 residues within 4Å:- Chain D: A.282, T.285, F.286
- Ligands: IVM.19
4 PLIP interactions:4 interactions with chain D- Hydrophobic interactions: D:A.282, D:T.285, D:F.286, D:F.286
OCT.20: 5 residues within 4Å:- Chain E: V.278, A.282, T.285, F.286
- Ligands: IVM.3
4 PLIP interactions:4 interactions with chain E- Hydrophobic interactions: E:V.278, E:A.282, E:T.285, E:F.286
- 1 x UND: UNDECANE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Hibbs, R.E. et al., Principles of activation and permeation in an anion-selective Cys-loop receptor. Nature (2011)
- Release Date
- 2011-05-25
- Peptides
- Avermectin-sensitive glutamate-gated chloride channel GluCl alpha: ABCDE
Mouse monoclonal Fab fragment, heavy chain: FGHIJ
Mouse monoclonal Fab fragment, light chain: KLMNO - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
FG
GH
HI
IJ
JK
KL
LM
MN
NO
O - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.35 Å
- Oligo State
- hetero-5-5-5-mer
- Ligands
- 5 x GLU: GLUTAMIC ACID(Non-covalent)
- 5 x IVM: (2aE,4E,5'S,6S,6'R,7S,8E,11R,13R,15S,17aR,20R,20aR,20bS)-6'-[(2S)-butan-2-yl]-20,20b-dihydroxy-5',6,8,19-tetramethyl-17 -oxo-3',4',5',6,6',10,11,14,15,17,17a,20,20a,20b-tetradecahydro-2H,7H-spiro[11,15-methanofuro[4,3,2-pq][2,6]benzodioxacy clooctadecine-13,2'-pyran]-7-yl 2,6-dideoxy-4-O-(2,6-dideoxy-3-O-methyl-alpha-L-arabino-hexopyranosyl)-3-O-methyl-alpha-L-arabino-hexopyranoside(Non-covalent)
- 3 x LMT: DODECYL-BETA-D-MALTOSIDE(Non-covalent)
- 1 x CL: CHLORIDE ION(Non-functional Binders)
- 3 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x OCT: N-OCTANE(Non-covalent)
- 1 x UND: UNDECANE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Hibbs, R.E. et al., Principles of activation and permeation in an anion-selective Cys-loop receptor. Nature (2011)
- Release Date
- 2011-05-25
- Peptides
- Avermectin-sensitive glutamate-gated chloride channel GluCl alpha: ABCDE
Mouse monoclonal Fab fragment, heavy chain: FGHIJ
Mouse monoclonal Fab fragment, light chain: KLMNO - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
FG
GH
HI
IJ
JK
KL
LM
MN
NO
O - Membrane
-
We predict this structure to be a membrane protein.